Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3D Perfusion Ultrasound for Liver Cancer SABR
NCT02424955Completed
- Sponsor
- Stanford University
- Start
- Nov 2014
- Primary completion
- Jun 2022
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Stanford University. Primary endpoints: Changes in Blood Perfusion (Blood Volume), Changes in Blood Perfusion (Mean Flow Velocity) and 1 more. Started Nov 2014; status: completed.
Beyond the preview
Go deeper on NCT02424955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02424955.